Last year, when Thailand overcame patent barriers that stood in the way of providing affordable medicines to treat HIV/AIDS, health activists stood up and cheered. When the European Commission, the United States, and the drug companies retaliated by threatening to impose trade sanctions or to wi
03/19/2008 - 10:29
Don't abuse patents: scientists The public sector has a key role in drug R&D. Patenting minor changes to extend monopoly prices spells misuse
08/17/2007 - 16:12
บทความนี้แปลจาก PhRMA's Seven Deadly Lies about Thai Compulsory Licenses ซึ่งเขียนโดย Brook K. Baker, Health GAP (วันที่ 1 กุมภาพันธ์ 2007)
02/09/2007 - 00:00
Bangkok, 29 November 2006 - the Royal Thai Government today announced that it would issue a government use licence to improve access to Efavirenz, a key HIV/AIDS medicine. Efavirenz is currently patent protected in Thailand , and the resulting monopolistic situation is limiting supply and affordability.
11/30/2006 - 01:00